AI Analysis AI Analysis of RDHL
AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment
Trading Strategy
PDF

Red day on Monday for Redhill Biopharma Ltd. stock after losing 2.80%
(Updated on Nov 17, 2025)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Oct 30, 2025 Loss -22.96%

The Redhill Biopharma Ltd. stock price fell by -2.80% on the last day (Monday, 17th Nov 2025) from $1.07 to $1.04. During the last trading day the stock fluctuated 4.83% from a day low at $1.04 to a day high of $1.09. The price has fallen in 5 of the last 10 days and is down by -18.11% for this period. Volume has increased on the last day by 11 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 65 thousand shares were bought and sold for approximately $67.47 thousand.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $1.01 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -6.65% during the next 3 months and, with a 90% probability hold a price between $0.94 and $2.27 at the end of this 3-month period.

RDHL Signals & Forecast

There are few to no technical positive signals at the moment. The Redhill Biopharma Ltd. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.07 and $1.54. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, October 01, 2025, and so far it has fallen -58.73%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Redhill Biopharma Ltd. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Redhill Biopharma Ltd. stock

Redhill Biopharma Ltd. finds support from accumulated volume at $1.02 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0500 between high and low, or 4.83%. For the last week, the stock has had daily average volatility of 4.14%.

Redhill Biopharma Ltd. is oversold on RSI14 (19). Some stock may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (RDHL) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect Redhill Biopharma Ltd. to open at $1.05, and during the day (based on 14 day Average True Range), to move between $0.97 and $1.11, which gives a possible trading interval of +/-$0.144 (+/-14.91%) up or down from last closing price. If Redhill Biopharma Ltd. takes out the full calculated possible swing range there will be an estimated 14.91% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.02 (1.92%) than the resistance at $1.08 (3.85%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Redhill Biopharma Ltd. stock A Buy?

Redhill Biopharma Ltd. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -4.715 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $1.05 ( 1.28%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk

RDHL Performance

Trading levels for RDHL

Full Access. No Commitment. 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 5 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 1.10 6.09%
R2 1.08 4.25%
R1 1.07 3.12%
Price 1.04
S1 1.03 -0.554%
S2 1.02 -1.69%
S3 1.00 -3.53%

Accumulated Volume Support & Resistance Levels

Level Price
R3 1.19 13.94%
R2 1.11 6.73%
R1 1.08 3.85%
Price 1.04
S1 1.02 -1.92%
S2 0 -
S3 0 -

FAQ

What is the symbol for Redhill Biopharma Ltd. Stock and on which exchange is it traded?
The symbol for Redhill Biopharma Ltd. is RDHL and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Redhill Biopharma Ltd. Stock?
Redhill Biopharma Ltd. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Redhill Biopharma Ltd. Stock?
Redhill Biopharma Ltd. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Redhill Biopharma Ltd. Stock.

What's the current price of Redhill Biopharma Ltd. Stock?
As of the end of day on the Nov 17, 2025, the price of an Redhill Biopharma Ltd. (RDHL) share was $1.04.

What is the 52-week high and low for Redhill Biopharma Ltd. Stock?
The 52-week high for Redhill Biopharma Ltd. Stock is $8.75 and the 52-week low is $1.02.

What is the market capitalization of Redhill Biopharma Ltd. Stock?
As of the Nov 17, 2025, the market capitalization of Redhill Biopharma Ltd. is 3.463M.
Click to get the best stock tips daily for free!
ABOUT REDHILL BIOPHARMA LTD.
Redhill Biopharma
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for the treatment of travelers' diarrhea in adults. Its clinical late-stage investigational development pr...
GOLDEN STAR
Ticker Change Signal Date
UNIT
$6.00
4.83% Nov 04
TBPH
$14.14
27.58% Oct 23
A
AMIX
$1.12
2.68% Oct 23
COCO
$40.85
11.21% Oct 23
LAUR
$29.55
1.20% Oct 22

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE